340B PATIENTS Act would stop drug companies from restricting where patients can fill prescriptions

AIDS Healthcare Foundation (AHF) applauds Representative Doris Matsui (D-CA) for her willingness to take on drug companies for their illegal contract pharmacy restrictions. As a 340B provider, AHF understands how contract pharmacy restrictions not only deny nonprofits vital savings but also interfere with their successful models of care.

“Drug companies have done everything possible to reduce the number of prescriptions available at 340B prices,” said Laura Boudreau, AHF Chief of Operations. “Drug makers have no right to determine where medically underserved patients fill prescriptions. The 340B PATIENTS Act is a crucial step in stopping a practice that puts profits over the health outcomes of vulnerable Americans. AHF is proud to support this bill.”

As 340B finds itself in the crosshairs of drug makers bent on the program’s destruction, the 340B PATIENTS Act will provide the necessary pushback. Drug makers have lobbied Congress to layer burdensome compliance standards onto healthcare nonprofits for nonexistent problems. Now, drug makers will face heavy fines for noncompliance.

AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 1.9 million individuals across 45 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, follow us on Instagram, Twitter, and TikTok, and subscribe to our AHFter Hours podcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240312980092/en/

Drug makers have no right to say where medically underserved patients fill prescriptions. The 340B Patients Act is a crucial step in stopping a practice that puts profits over the health outcomes of vulnerable Americans. AHF is proud to support this bill.